16 September 2024

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

16 September 2024 | n=32

  1. Kuniholm MH, Murenzi G, Shumbusho F, Brazier E, et al.
    Association of cardiovascular disease risk with liver steatosis and fibrosis in people living with hiv in low- and middle-income countries.
    AIDS 2024.

  2. Sahu M, Schaafsma T, Szpiro AA, Van Rooyen H, et al.
    Performance of patient-collected dried blood spot specimens for HIV-1 viral load testing: evidence from the DO ART Study in South Africa.
    AIDS 2024.

  3. Cummings TH, Magagnoli J, Sikirzhytskaya S, Tyagin I, et al.
    Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among People Living with HIV.
    AIDS 2024.

  4. Vidal JE, Duarte AN, Chow FC, Duarte MIS, et al.
    Does "Toxoplasma abscess" Properly Describe Brain Lesions Caused by Toxoplasma gondii?
    Clin Infect Dis 2024.

  5. Weijsenfeld A, van der Knaap L, Sattoe J, van Staa A, et al.
    Health-related quality of life in young adults with perinatal HIV after transfer to adult health care in the Netherlands.
    J Acquir Immune Defic Syndr 2024.

  6. Reisner SL, Humes E, Stevenson M, Cooney EE, et al.
    Site-based and Digital Cohort Participation Among Transgender Women in the Eastern and Southern USA: Findings from the LITE Study.
    J Acquir Immune Defic Syndr 2024.

  7. .
    Brief Report: HIV-1 Resistance Analysis of Participants With HIV-1 and Hepatitis B Initiating Therapy With Bictegravir/Emtricitabine/Tenofovir Alafenamide or Dolutegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate: A Subanalysis of ALLIANCE Data
    J Acquir Immune Defic Syndr 2024;97:202.

  8. Orr JE, Velazquez J, Schmickl CN, Bosompra NO, et al.
    Sleep, Sleep Apnea, and Fatigue in People Living With HIV.
    J Acquir Immune Defic Syndr 2024;97:192-201.

  9. Lazzaro A, Vai D, Barco A, Stroffolini G, et al.
    Switching to Low Neurotoxic Antiretrovirals to Improve Neurocognition Among People Living With HIV-1-Associated Neurocognitive Disorder: The MARAND-X Randomized Clinical Trial.
    J Acquir Immune Defic Syndr 2024;97:180-191.

  10. Masheto G, Brummel SS, Ziemba L, Shepherd J, et al.
    Markers of Maternal Bone and Renal Toxicity Through 50 Weeks Postpartum: IMPAACT 2010 (VESTED) Trial.
    J Acquir Immune Defic Syndr 2024;97:172-179.

  11. Debroy P, Barrett BW, Erlandson KM, Budoff M, et al.
    Relationships Between Hepatic Steatosis and Frailty Differ by HIV Serostatus.
    J Acquir Immune Defic Syndr 2024;97:165-171.

  12. Aouizerat BE, Garcia JN, Domingues CV, Xu K, et al.
    Frequent Cocaine Use is Associated With Larger HIV Latent Reservoir Size.
    J Acquir Immune Defic Syndr 2024;97:156-164.

  13. Beltran RM, Hunter LA, Packel LJ, De Martini L, et al.
    A Mixed Methods Evaluation of Pharmacists' Readiness to Provide Long-Acting Injectable HIV Pre-exposure Prophylaxis in California.
    J Acquir Immune Defic Syndr 2024;97:142-149.

  14. MacGowan RJ, Chavez PR, Dana R, Hannah M, et al.
    Efficacy of Internet Recruitment and HIV Self-Testing for Diagnosing HIV Infections Among Black and Hispanic/Latino MSM and Transgender Women in 11 US States, 2020-2021.
    J Acquir Immune Defic Syndr 2024;97:133-141.

  15. Mujugira A, Karungi B, Nakyanzi A, Bagaya M, et al.
    Peer-Delivered HIV Self-Testing, Sexually Transmitted Infection Self-Sampling, and Pre-exposure Prophylaxis for Transgender Women in Uganda: A Randomized Trial.
    J Acquir Immune Defic Syndr 2024;97:125-132.

  16. McDonald SA, Yeung A, Nandwani R, Clutterbuck D, et al.
    A Statistical Model for Inference of Recent and Incident HIV Infection Using Surveillance Data on Individuals Newly Diagnosed With HIV Infection in Scotland.
    J Acquir Immune Defic Syndr 2024;97:117-124.

  17. Yang X, Zhang J, Chen S, Liu Z, et al.
    COVID-19 Breakthrough Infections Among People With HIV: A Statewide Cohort Analysis.
    J Acquir Immune Defic Syndr 2024;97:107-116.

  18. Yigit I, Budhwani H, Rainer CB, Claude K, et al.
    Associations Between PrEP Stigma, PrEP Confidence, and PrEP Adherence: Conditional Indirect Effects of Anticipated HIV Stigma.
    J Acquir Immune Defic Syndr 2024;97:99-106.

  19. Michael HU, Brouillette MJ, Tamblyn R, Fellows LK, et al.
    Disentangling the Effects of Comorbidity and Polypharmacy on Cognitive Function and Physical Frailty in Individuals with HIV.
    J Acquir Immune Defic Syndr 2024.

  20. Bell GJ, Chen JS, Maierhofer CN, Matoga M, et al.
    Updated Risk Score Algorithms for Acute HIV Infection Detection at a Sexually Transmitted Infections Clinic in Lilongwe, Malawi.
    J Acquir Immune Defic Syndr 2024.

  21. DeJesus E, Towner WJ Jr, Gathe JC, Cash RB, et al.
    Efficacy and safety of two fixed doses of ibalizumab plus optimized background regimen in treatment-experienced HIV-positive individuals.
    J Acquir Immune Defic Syndr 2024.

  22. El-Hibri F, Al-Hindawi A, Singh S, Bower M, et al.
    Outcomes of lymphoma patients admitted to the ICU are not influenced by HIV status: a retrospective, observational cohort study.
    J Acquir Immune Defic Syndr 2024.

  23. Travieso T, Stadtler H, Alavian N, Gao F, et al.
    Longitudinal analysis of viral dynamics in HIV+ to HIV+ HOPE Act kidney-transplant recipients.
    J Clin Invest 2024.

  24. Nguyen HT, Chikata T, Zhang Y, Tran GV, et al.
    Role of HLA-B*58:01-restricted CD8+ T cells in HIV-1 subtype AE infection.
    J Infect Dis 2024.

  25. Srinivasan S, Richardson BA, Wallis JM, Fiedler TL, et al.
    Vaginal Bacteria and Proinflammatory Host Immune Mediators as Biomarkers of Human Immunodeficiency Virus Acquisition Risk Among African Women.
    J Infect Dis 2024.

  26. Gay L, Desquiret-Dumas V, Nagot N, Rapenne C, et al.
    Long-term persistence of mitochondrial dysfunctions after viral infections and antiviral therapies: A review of mechanisms involved.
    J Med Virol 2024;96:e29886.

  27. Zankharia U, Yi Y, Lu F, Vladimirova O, et al.
    HIV-induced RSAD2/Viperin supports sustained infection of monocyte-derived macrophages.
    J Virol 2024.

  28. Marchitto L, Richard J, Prevost J, Tauzin A, et al.
    The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity.
    J Virol 2024.

  29. Zhang S, Anang S, Zhang Z, Nguyen HT, et al.
    Conformations of membrane human immunodeficiency virus (HIV-1) envelope glycoproteins solubilized in Amphipol A18 lipid-nanodiscs.
    J Virol 2024.

  30. Julg B, Walker-Sperling VEK, Wagh K, Aid M, et al.
    Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial.
    Nat Med 2024.

  31. Navarro C, Lau C, Buchan SA, Burchell AN, et al.
    Effectiveness of modified vaccinia Ankara-Bavarian Nordic vaccine against mpox infection: emulation of a target trial.
    BMJ 2024;386:e078243.

  32. Dal-Re R, Bekker LG, Jha V, Le Louarn A, et al.
    Navigating US participant data sharing requirements: implications for international clinical trials.
    BMJ 2024;386:e079701.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

14 October 2024

07 October 2024

30 September 2024

23 September 2024

16 September 2024


16 September 2024

Multidisciplinary Journal Club

  1. .
    General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7.5 million participants.
    Lancet. 2024;404:851-863.

  2. McIntyre WF, Benz AP, Healey JS, Connolly SJ, et al.
    Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial.
    Circulation. 2024 Sep 4. doi: 10.1161/CIRCULATIONAHA.124.069903.

  3. Mulder MJHL, Cras TY, Shay J, Dippel DWJ, et al.
    Comparison of American and European Guideline Recommendations for Diagnostic Workup and Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack.
    Circulation. 2024;150:806-815.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Privacy Policy